Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors
一项关于非清髓性异基因骨髓移植治疗B细胞淋巴瘤的II期研究，该研究采用移植后利妥昔单抗治疗，并首先基于非HLA因素选择供体。
期刊:Biology of Blood and Marrow Transplantation
影响因子:
doi:10.1016/j.bbmt.2015.07.012
Kanakry, Jennifer A; Gocke, Christopher D; Bolaños-Meade, Javier; Gladstone, Douglas E; Swinnen, Lode J; Blackford, Amanda L; Fuchs, Ephraim J; Huff, Carol Ann; Borrello, Ivan; Matsui, William H; Brodsky, Robert A; Rosner, Gary L; Shanbhag, Satish; Luznik, Leo; Jones, Richard J; Ambinder, Richard F; Kasamon, Yvette L
